Anxiety disorders: Dental implications

General Dentistry

Volumn 51, Issue 6, 2003, Pages 562-568

  Little, James W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPRAZOLAM; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORDIAZEPOXIDE; CIMETIDINE; DIAZEPAM; ERYTHROMYCIN; FENTANYL; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MIDAZOLAM; MONOAMINE OXIDASE INHIBITOR; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NITROUS OXIDE; PAROXETINE; PHENELZINE; PROMETHAZINE; SALICYLIC ACID DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STEROID; UNINDEXED DRUG; WARFARIN; ANXIOLYTIC AGENT;

ACUTE STRESS DISORDER; AGGRESSION; AGORAPHOBIA; AGRANULOCYTOSIS; AKATHISIA; ANEMIA; ANOREXIA; ANORGASMIA; ANXIETY DISORDER; BLEEDING; BRADYCARDIA; CLAUSTROPHOBIA; CLINICAL FEATURE; COGNITIVE DEFECT; CONSTIPATION; DENTAL CARE; DENTISTRY; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DROWSINESS; DRUG POTENTIATION; DYSKINESIA; DYSTONIA; ERECTILE DYSFUNCTION; GASTROINTESTINAL REFLUX; GENERALIZED ANXIETY DISORDER; GYNECOMASTIA; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPOTENSION; HYPOTHYROIDISM; IMPULSIVENESS; INCIDENCE; INSOMNIA; INVOLUNTARY MOVEMENT; LEUKOPENIA; LIBIDO DISORDER; LOW DRUG DOSE; MANIA; MENTAL HEALTH; NAUSEA; NERVOUSNESS; NEUROLEPTIC MALIGNANT SYNDROME; OBSTRUCTIVE JAUNDICE; ORTHOSTATIC HYPOTENSION; PANIC; PARKINSONISM; PATIENT REFERRAL; POSTTRAUMATIC STRESS DISORDER; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIAL PHOBIA; STROKE; SWEATING; TACHYCARDIA; TARDIVE DYSKINESIA; TERRORISM; TOXICITY; UNITED STATES; URINE RETENTION; VISUAL IMPAIRMENT; VOMITING; WEIGHT REDUCTION; XEROSTOMIA; BEHAVIOR THERAPY; CLASSIFICATION; DRUG INTERACTION; PSYCHOLOGICAL ASPECT;

ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BEHAVIOR THERAPY; DENTAL CARE FOR CHRONICALLY ILL; DRUG INTERACTIONS; HUMANS; TERRORISM;

EID: 4344681378     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Vogel LR, Muskin PR. Anxiety disorders. In: Cutler JL, Marcus ER, eds. Psychiatry. Philadelphia: W.B. Saunders Co.;1999:105-127.
2. Task Force on DMS-IV, American Psychiatric Association. Anxiety disorders. Diagnostic and statistical manual of mental disorders DSM-IV-TR (text revision), ed. 4. Washington, DC: American Psychiatric Press;2000.
3. Little JW, Falace DA, Miller CS, Rhodus NL. Behavioral and psychiatric disorders. Dental management of the medically compromised patient, ed. 6. St. Louis: Mosby; 2002:439-478.
4. Kendler KS, Myers J, Prescott CA. The etiology of phobias: An evaluation of the stress-diathesis model. Arch Gen Psychiatry 2002;59:242-248.
5. Kendler KS, Jacobson KC, Myers J, Prescott CA. Sex differences in genetic and environmental risk factors for irrational fears and phobias. Psychol Med 2002;32:209-217.
6. Davey GC. 'Nonspecific' rather than 'nonassociative' pathways to phobias: A commentary on Poulton and Menzies. Behav Res Ther 2002;40:151-158.
7. Goodwin RD, Hamilton SP. The early-onset fearful panic attack as a predictor of severe psychopathology. Psychiatry Res 2002;109:71-79.
8. Katerndahl DA. Factors influencing care seeking for a self-defined worst panic attack. Psychiatr Serv 2002;53:464-70.
9. Goldberg RJ. Practical guide to the care of the psychiatric patient. St. Louis: Mosby;1995.
10. Culpepper L. Generalized anxiety disorder in primary care: Emerging issues in management and treatment. J Clin Psychiatry 2002;63 Suppl 8:35-42.
11. Kessler RC, Wittchen HU. Patterns and correlates of generalized anxiety disorder in community samples. J Clin Psychiatry 2002;63 Suppl 8:4-10.
12. Keller MB. The long-term clinical course of generalized anxiety disorder. J Clin Psychiatry 2002;63 Suppl 8:11-16.
13. Seedat S, Stein MB. Post-traumatic stress disorder: A review of recent findings. Curr Psychiatry Rep 2001;3:288-294.
14. Schlenger WE, Caddell JM, Ebert L, Jordan BK, Rourke KM, Wilson D, Thalji L, Dennis JM, Fairbank JA, Kulka RA. Psychological reactions to terrorist attacks: Findings from the National Study of Americans' Reactions to September 11. JAMA 2002;288:581-588.
15. Judd LL, Britton KT, Braff DL. Mental Disorders. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, ed. Harrison's principles of internal medicine, ed. 13. New York: McGraw-Hill, Inc.; 1994:2400-2420.
16. Reus V. Psychiatric disorders. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, ed. Harrison's principles of internal medicine, ed. 14. New York: McGraw-Hill; 1998:2485-2502.
17. Friedlander AH, Gorelick DA. Panic disorder: Its association with mitral valve prolapse and appropriate dental management. Oral Surg Oral Med Oral Pathol 1987;63:309-312.
18. North CS. The course of post-traumatic stress disorder after the Oklahoma City bombing. Mil Med 2001;166(12 Suppl):51-52.
19. Schuster MA, Stein BD, Jaycox L, Collins RL, Marshall GN, Elliott MN, Zhou AJ, Kanouse DE, Morrison JL, Berry SH. A national survey of stress reactions after the September 11, 2001, terrorist attacks. N Engl J Med 2001;345:1507-1512.
20. Psychological and emotional effects of the September 11 attacks on the World Trade Center - Connecticut, New Jersey, and New York, 2001. MMWR Morb Mortal Wkly Rep 2002;51:784-786.
21. CDC. Community needs assessment of lower Manhattan residents following the World Trade Center attacks - Manhattan, New York City, 2001. MMWR Morb Mortal Wkly Rep 2002;51 Spec No:10-13.
22. CDC. Injuries and illnesses among New York City Fire Department rescue workers after responding to the World Trade Center attacks. MMWR Morb Mortal Wkly Rep 2002; 51 Spec No:1-5.
23. CDC. Impact of September 11 attacks on workers in the vicinity of the World Trade Center - New York City. MMWR Morb Mortal Wkly Rep 2002; 51 Spec No:8-10.
24. Pereira A. Combat trauma and the diagnosis of post-traumatic stress disorder in female and male veterans. Mil Med 2002;167:23-27.
25. Davis LL, English BA, Ambrose SM, Petty F. Pharmacotherapy for post-traumatic stress disorder: A comprehensive review. Expert Opin Pharmacother 2001;2:1583-1595.
26. Ashton CH. Insomnia and anxiety. In: Walker R, Edwards C, ed. Clinical pharmacy and therapeutics, ed. 2. London: Churchill Livingston;1999:393-409.
27. Smith CM. Antianxiety drugs. In: Smith CM, Reynard AM, ed. Textbook of pharmacology. Philadelphia: W.B. Saunders; 1992:271-298.
28. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1794-1801.
29. Friedlander AH, Mills MJ, Wittlin BJ. Dental management considerations for the patient with post-traumatic stress disorder. Oral Surg Oral Med Oral Pathol 1987;63:669-673.
30. Winter JC. Antipsychotic drugs (antipsychotics). In: Smith CM, Reynard AM, ed. Textbook of pharmacology. Philadelphia: W.B. Saunders;1992:298-309.
31. Judd L. The therapeutic use of psychotropic medications. In: Fauci A, Martin JB, Petersdorf RG, ed. Harrison's principles of internal medicine, ed. 12. New York: McGraw-Hill;1991:2139-2154.
32. van der Bijl P. The benzodiazepines in dentistry: A review. Compendium 1992;13:46-52.